Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 29 (RN7SKP29) is a non-functional, processed pseudogene derived from the functional RN7SK gene, which encodes the 7SK small nuclear RNA. The original RN7SK plays a critical role in transcriptional regulation by controlling the positive transcription elongation factor P-TEFb and affects cell differentiation, proliferation, and gene expression regulation[1][2][3][4]. However, RN7SKP29 itself does not produce a functional RNA or protein, has no direct biological function, is not considered a therapeutic target, and has no established involvement in human disease.
Not a functional target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 29 (RN7SKP29).